Related Experiment Video
Updated: Nov 1, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Prevalence of Aortic Valve Stenosis in Patients With ST-Segment Elevation Myocardial Infarction and Effect on
Gurpreet K Singh1, Pieter van der Bijl1, Laurien Goedemans1
1Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Aortic valve stenosis (AS) is present in nearly 3% of ST-segment elevation myocardial infarction (STEMI) patients and is linked to increased long-term mortality risk. Early detection of AS in STEMI patients is crucial for better outcomes.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Echocardiography
Background:
- Aortic valve stenosis (AS) is associated with atherosclerosis and cardiovascular risk factors.
- These risk factors are common in patients experiencing ST-segment elevation myocardial infarction (STEMI).
Purpose of the Study:
- To determine the prevalence of aortic valve stenosis (AS) in patients presenting with STEMI.
- To assess the prognostic impact of AS on all-cause mortality in this patient group.
Main Methods:
- A cohort of 2041 STEMI patients treated with primary percutaneous coronary intervention was analyzed.
- Echocardiography was used to diagnose AS (aortic valve area ≤2.0 cm²).
- Patients were categorized into groups based on AS presence, sclerosis, or normal aortic valves.
Main Results:
- The prevalence of AS was 2.7% overall, increasing significantly with age.
- Patients with AS exhibited a higher mortality rate compared to other groups (p < 0.001).
- AS was an independent predictor of all-cause mortality (HR 1.81, p = 0.04).
Conclusions:
- Aortic valve stenosis is a relevant comorbidity in patients with first STEMI.
- Concomitant AS independently predicts long-term all-cause mortality in STEMI patients.
Abstract:
Several studies have shown an association between aortic valve stenosis (AS), atherosclerosis and cardiovascular risk factors. These risk factors are frequently encountered in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to evaluate the prevalence and the prognostic implications of AS in patients presenting with STEMI. A total of 2041 patients (61 ± 12 years old, 76% male) admitted with STEMI and treated with primary percutaneous coronary intervention were included. Patients with previous myocardial infarction and previous aortic valve replacement were excluded. Echocardiography was performed at index admission. Patients were divided in 3 groups: 1) any grade of AS, 2) aortic valve sclerosis and 3) normal aortic valve. Any grade of AS was defined as an aortic valve area ≤2.0 cm2. The primary endpoint was all-cause mortality. The prevalence of AS was 2.7% in the total population and it increased with age (1%, 3%, 7% and 16%, in the patients aged <65 years, 65 to 74 years, 75 to 84 years and ≥85 years, respectively). Patients with AS showed a significantly higher mortality rate when compared to the other two groups (p < 0.001) and AS was independently associated with all-cause mortality, with a HR of 1.81 (CI 95%: 1.02 to 3.22; p = 0.04). In conclusion, AS is not uncommon in patients with STEMI, and concomitant AS in patients with first STEMI is independently associated with all-cause mortality at long-term follow up.
More Related Videos
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

